Sanjiv Patel
CEO, President at Relay Therapeutics, Inc. (RLAY)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 8SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 48,199471,301 held (−9%) | $18.10 | $872K | -1.2% |
| Sep 9SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 48,199519,500 held (−8%) | $18.94 | $913K | -5.6% |
| Aug 18SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 48,199567,699 held (−8%) | $20.33 | $980K | -12.1% |
| Jul 8SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 48,199615,898 held (−7%) | $19.58 | $944K | -8.7% |
| Jan 7SEC | RLAYRelay Therapeutics, Inc. | Sell | 43,168661,041 held (−6%) | $7.82 | $338K | +128.6% |
| Nov 4SEC | RLAYRelay Therapeutics, Inc. | Sell | 62,073703,215 held (−8%) | $7.00 | $435K | +155.4% |
- Sell
CEO, President Sanjiv Patel sold $872K of RLAY at $18.10 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Sanjiv Patel sold $913K of RLAY at $18.94 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Sanjiv Patel sold $980K of RLAY at $20.33 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Sanjiv Patel sold $944K of RLAY at $19.58 — pre-scheduled 10b5-1 plan sale.